Viagra Buys Botox & Why You Should Buy Pfizer

Kent Kwan

AtlasTrend

Pfizer, one of the world’s largest pharmaceutical companies (and the maker of Viagra), has recently announced it is merging with Allergan, best known for being the maker of Botox. Despite being called a merger, the implications of what is effectively Pfizer acquiring Allergan for US$160 billion go well beyond their two most famous products. We think if this transaction proceeds it will create a great outcome for investors. Here are our key reasons why you should consider investing in Pfizer now. Read more at this (VIEW LINK)


Kent Kwan
Co-Founder
AtlasTrend

Kent Kwan is a co-founder of AtlasTrend. He was formerly a Chief Investment Officer of an ASX listed company and prior to that was an international equities fund manager with JPMorgan.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.